Act before it's too late! GlyCardial Diagnostics is a spin-off company of the Catalan Institute of Cardiovascular Sciences (ICCC) and the Spanish National Research Council (CSIC) focused on the development of a novel in vitro diagnostic device for myocardial ischemia. The technology is based on the detection of Apo J-Glyc in blood as a biomarker for the early diagnosis of cardiac ischemia and the prediction of patient’s evolution after an ischemic event. GlyCardial Diagnostics was created by scientists Lina Badimon, Judit Cubedo, Teresa Padró and Gemma Vilahur. The company is located at the Hospital de la Santa Creu i Sant …

62 similar entities Type: Startup Activities: biotech deeptech healthtech

Coala Heart Monitor System Coala Solutions is a medical technology and life science company focusing on heart diagnostics and digital health. The company has developed a portfolio of solutions based on the Coala, a patented and commercial service for remote monitoring and self-screening of heart sounds and ECG. The Coala is available to healthcare organizations to enable smart, digital cardiac assessments. CE and FDA cleared. We make it possible for everyone to monitor their heart. Cardiovascular diseases are one of the leading causes of death around the world. A key contributor is late diagnosis. Coala Life was founded as a …

72 similar entities Type: Startup Activities: healthtech deeptech Technologies: IoT

Digital therapeutics for chronic cardiovascular disease CardioRenal is a company dedicated to improving the quality of treatment for heart failure patients through the use of state-of-the art technology (expert systems, real-time diagnosis, microfluidics, etc.) combined with top medical expertise. CardioRenal est une société qui développe une solution de télé-médecine qui permet de mesurer des biomarqueurs chez un patient à domicile et ainsi d'adapter en temps réel la thérapie en fonction de l'état du patient. Nous ciblons les patients insuffisants cardiaques. Grâce à un accord de licence avec un laboratoire pharmaceutique nous visons une commercialisation à grande échelle à relativement court …

103 similar entities Type: Startup Activities: deeptech healthtech Technologies: A.I.

Know what counts -- for the heart and blood vessels. The DGFF (Lipid League) e. V. was founded in October 1988 in Wiesbaden. Since June 27, 2024 it has been called the German Society for Lipidology. V. (DGFL) – Lipid League. At that time, the public controversy about the causes of hypercholesterolemia caused a stir and unsettled both the medical profession and the population. That's why scientists came together to make the discussions more objective. Today's DGFL (Lipid League) established itself as an independent contact for questions relating to lipid metabolism and atherosclerosis; it provides information and trains doctors to …

56 similar entities Type: SMB Activities: deeptech healthtech

Driven by the heart We officially combined with Bristol Myers Squibb to further strengthen our scientific capabilities and treatments for cardiovascular patients. Visit www.bms.com to learn more about our work to produce the next generation of medicines for patients with serious cardiovascular disease. For more information on the acquisition, see our press release at: https://one.bms.com/40FsT7W Genetic Heart Disease, Cardiomyopathy, biotechnology, cardiovascular disease, heart failure, precision medicine, therapeutics, drug discovery, drug development, and R&D

Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology

Olva Medical is a medtech company specializing in the field of cardiology. Olva Medical develops a portable and reusable electrophysiology platform. Electrophysiology interventions allow for the treatment of cardiac arrhythmias, a major public health issue. These arrhythmias lead to a decrease in quality of life and increased mortality: 20% of strokes are caused by atrial fibrillation, the most common arrhythmia. With the aging global population, the number of cardiovascular patients is increasing significantly. At the same time, hospitals' financial and material resources are becoming increasingly constrained. Our solution, an electrophysiology platform that fits into a briefcase with reusable catheters, allows …

105 similar entities Type: Startup Activities: deeptech healthtech Technologies: SaaS

Assessment of the uniqueness of diabetic cardiomyopathy relative to other forms of heart failure The aim of CARDIATEAM is to determine whether T2DM represents a central mechanism contributing to the pathogenesis and progression of a specific cardiomyopathy, called “diabetic cardiomyopathy” (DCM), assessing whether DCM is unique and distinct from the other forms of heart failure. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 821508. diabetes, heart failure, and omics

60 similar entities Type: Startup Activities: deeptech

The Heart Rhythm Disease Institute (French: L'Institut des maladies du RYthme Cardiaque), is one of 6 French university hospital institutions created in 2011 as part of the investments in the future program ("Investissements d'avenir"​) to boost medical research and innovation. This institute, created by Professor Michel Haissaguerre along with cardiology teams of the University Hospital of Bordeaux, unites multiple specialties around cardiac electrophysiology from research on ionic channels (microgenerators producing electric flows in cells) to whole heart and patient care. LIRYC is a basic research, clinical and teaching centre focusing on the understanding, care and treatment of cardiac electrical diseases …

84 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Advancing cardiovascular care through science, innovation, and a commitment to better patient outcomes worldwide Amarin is a global pharmaceutical company committed to reducing the cardiovascular disease (CVD) burden for patients and communities and to advancing the science of cardiovascular care around the world. We own and support a global branded product approved by multiple regulatory authorities based on a track record of proven efficacy and safety and backed by robust clinical trial evidence. Our commercialization model includes a direct sales approach in the U.S. and an indirect distribution strategy internationally through a syndicate of reputable and well-established partners with significant …

190 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Finding cures for cardiovascular disease through world-class medical research. The Victor Chang Cardiac Research Institute is dedicated to finding cures for cardiovascular disease through world-class medical research. Renowned for the quality of its scientific breakthroughs, the team at the Institute is working urgently to discover better ways of diagnosing, treating and preventing the onset of heart disease. With over 200 scientists and doctors working together across 23 laboratories in NSW and WA, the Victor Chang Cardiac Research Institute has earned its place on the global stage as one of the most respected medical research facilities in the world. The Institute …

57 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Dispositif Médical Numérique de prise en charge à distance de l'insuffisance cardiaque chronique. CareLine is a multimodal remote monitoring solution for heart failure patients based on clinical, biological and therapeutic criteria. Patients are equipped with connected objects (weight scales, blood pressure monitors) to monitor their pathology at home and receive support and therapeutic education for their heart failure. Daily remote monitoring makes it possible to anticipate and detect a sudden worsening of the disease and also to ensure a rapid medical care. CareLine invests in research in collaboration with the IHU LIRYC of Bordeaux and the Institute of Cardiology of …

107 similar entities Type: Startup Activities: healthtech deeptech Technologies: A.I.

Clinical Genetics and Precision Medicine. Safeguarding your future health. GENinCode specializes in risk assessment and prediction of cardiovascular disease , thrombosis and familial hypercholesterolemia . Cardiovascular disease (CVD) is a broad disease classification including coronary artery disease such as angina and myocardial infarction often referred to as heart attack. CVD also includes stroke, heart failure, hypertension and other vascular heart diseases and is the leading cause of death and disability worldwide accounting for 1 in every 4 deaths in the United States. GENinCode provides advanced genomic technology, products and recommendations fully validated by our scientific and clinical team. Our goal …

61 similar entities Type: Startup Activities: healthtech deeptech

The word of the heart Bits2beat Predictive Analytics is an information and medical technology company working to prevent stroke, a public health issue that remains unresolved today. It develops a SaMD (Software as a Medical Device) from data science applied to cardiology. Its innovative AI, for the acquisition and semantic interpretation of the heart rate, with any consumer connected device, disrupts the existing practice that is not ergonomic enough or efficient enough. It will allow screening of the main risk factors for stroke, including heart rhythm disorders, massively in the population at risk. cardiologie, logiciel médical, Software as a Medical …

117 similar entities Type: Startup Activities: healthtech deeptech Technologies: A.I.

Our mission for +25 years is to take care of people's health with an eye toward the future and innovation. We are moved by values ​​such as commitment, honesty and the desire to improve. Thanks to them and our team we have become the 3rd pharmaceutical laboratory that sells the most units in Spanish pharmacies. We are also pioneers in biosimilar drugs in Spain and Portugal and we also have a line of self-care products, sports nutrition under the Finisher brand and women's health under the Gynea brand. Our vocation to serve society means that we are always close to …

271 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Your Global Connection to the Biomedical Engineering Community IEEE Engineering in Medicine and Biology Society (EMBS) is the world's largest international society of biomedical engineers. The organization's 12,000+ members reside in some 97 countries around the world. EMBS provides its members with access to the people, practices, information, ideas and opinions that are shaping one of the fastest growing fields in science. EMBS members come from everywhere and every walk of life. They work in industry, academic institutions, hospitals, entrepreneurs and government agencies. They design the electrical circuits that make a pacemaker run...create the software that reads an MRI...and help …

64 similar entities Type: SMB Activities: deeptech biotech healthtech nanotech Technologies: Robotics Wireless

Helping health & biotech companies, researchers and entrepreneurs making their projects and dreams come true. GENESIS Biomed is a consultancy firm in the biomedical healthcare sector specialized in providing consulting services in the genesis and first phases of lifecycle of biomedical spin-off and start-up companies, entrepreneurs and research centers. Based in our expertise we help entrepreneurs and researchers to shape their business plan and we support them in the private fundraising process. We have raised 68,5 M€ in the last years in 20 rounds. We are Associate Partner at EIT Health and we are engaged to 23 EU projects with …

254 similar entities Type: SMB Activities: deeptech healthtech consulting entrepreneurship fintech biotech Technologies: A.I.

CorFlow is developing a system that will be the first to detect & treat microvascular obstruction (MVO) in real time. CorFlow was founded on the belief that current PCI and cardiac care remains suboptimal due the fact that underlying microvascular dysfunction and obstruction is not detected and treated adequately. CorFlow believes, like much of the medical community, that the next frontier of innovation and positive impact on clinical outcomes in cardiology and beyond will come from the microvascular space. Our first solution is a system that will be the first to diagnose microvascular obstruction (MVO) in real time during PCI …

121 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Voted Best Contract Research Organization (CRO) 2024 by Citeline CMIC Group was the first company to provide CRO (contract research organization) services in Japan. Relevant laws and rules had not been established when the group was first established. The CRO Study Group (which later became the Japan CRO Association) was formed by Mr. Kazuo Nakamura, the current CEO of CMIC Group, and others to conduct promotion and public relations activities and to negotiate with the authorities for the establishment of CROs in Japan. CMIC Group offers extensive services that encompass an entire value-chain of pharmaceutical companies, including manufacturing, sales, and …

158 similar entities Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Developing novel medications for patients with atrial fibrillation InCarda Therapeutics is a privately held biotechnology company backed by leading VC investors, Deerfield Management and HealthCap, developing novel drugs for the treatment of patients with atrial fibrillation (“AF”). Our mission is to enable rapid restoration of normal sinus rhythm ("NSR") with therapies designed to be fast-acting, safe, simple to use, and available across the continuum of care—from hospital-based cardioversion to at-home, self-administered treatment. Cardiovascular, Biotechnology, Pharmaceuticals, Clinical Development, Drug Formulation, Clinical Research, Pre-Clinical Research, atrial fibrillation, and arrhythmias

127 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Insmed is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. We are dedicated to making a meaningful impact in patients’ lives as well as the communities where we live and work. Our team is guided by our core values of collaboration, accountability, passion, respect, and integrity. Insmed is headquartered in Bridgewater, NJ, and has offices and research locations throughout the United States, Europe, and Japan. We are proud to be recognized as one of the best employers in the biopharmaceutical industry, including spending five consecutive years as …

260 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Excellence for Life BIOTRONIK is a global medical device company providing products and services for the treatment of cardiovascular and endovascular diseases. Patient well-being is our main priority. For 60 years, we have been driven by the desire to save lives and improve the quality of life of patients. With thousands of employees in more than 100 countries, we are among the world's leading medical technology innovators in the areas of cardiac rhythm management, electrophysiology and vascular intervention. Our technology empowers doctors around the world to provide their patients with the best possible healthcare. Heart rate management Implantable devices help …

140 similar entities Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

LTSI's research is at the interface of disciplines in the fields of information and health sciences and technologies. Their aims are methodological, technological and clinical and their purposes are interpretation and decision support. They revolve around the core ‘signal-model-image’, these three components providing essential added value. The work is carried out within five teams. Each team is focused on a specific target and is formed around a multidisciplinary group capable of integrating the most recent physiological knowledge in the field into its approach and identifying the underlying methodological questions. The work of the CINETYKS team concerns the dynamics of neuronal …

92 similar entities Type: SMB Activities: deeptech biotech Technologies: Data Analytics

Cardiac Microcurrent C-MIC - A novel therapy for chronic heart failure Berlin Heals is a Start-up-Company in Berlin, Germany. We are devoted to the treatment of heart failure. We will redefine heart failure treatment with a novel device that is capable of healing the heart. Contact us at info@berlinheals.de to get in touch with us. Get more Information here: www.berlinheals.de R+D and Marketing of a novel cardiovascular device

67 similar entities Type: Startup Activities: deeptech healthtech biotech

about people about health Even before being a company, we are people at the service of people. Founded in 1984, ab medica is today the leading Italian company in the production and distribution of medical technologies and wearable medical devices, as well as a point of reference for #arobotic surgery and #telemedicine. The Group includes ab medica A TLC (leading company in the global telecommunications market), Medical Labs (production of medical devices for minimally invasive surgery), Pacinotti (distribution of medical devices) and ab salud (distribution of medical devices in Spain). The international network includes ab medica sas (France), ab medica …

317 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology